CTLA4 and neoplasm: Downregulation of AL031775.1 in T cells resulted in a significant decrease in T cell proliferation, an increase in apoptosis, and a reduced capacity for tumor cell lysis, accompanied by elevated expression of immune checkpoints LAG3, CTLA4, and PD1 (Figures 8A–C, G, H).